Loading clinical trials...
Loading clinical trials...
RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS. A Randomized Trial of Long-term Dosage of Rituximab in Multiple Sclerosis
Conditions
Interventions
Rituximab
Locations
17
Sweden
Anders Svenningsson
Danderyd, Stockholm County, Sweden
South Älvsborg Hospital
Borås, Sweden
Falun Hospital
Falun, Sweden
Gävle Hospital
Gävle, Sweden
Saghlgrenska Hospital
Gothenburg, Sweden
Helsingborg Hospital
Helsingborg, Sweden
Start Date
July 4, 2018
Primary Completion Date
December 20, 2024
Completion Date
June 1, 2025
Last Updated
April 19, 2021
NCT05359653
NCT06390930
NCT03401879
NCT06389968
NCT05834855
NCT06413602
Lead Sponsor
Karolinska Institutet
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions